Welcome to our dedicated page for Trio Tech Int SEC filings (Ticker: TRT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking the financial pulse of a semiconductor service company that also makes its own test gear and even holds real estate can feel like soldering without a schematic. Trio Tech International’s SEC reports weave together segment revenue from global burn-in labs, depreciation on Van Nuys equipment, and rental income from industrial property—details that easily hide in 300-page documents.
Stock Titan resolves that problem. Our platform delivers Trio Tech International SEC filings explained simply: AI distills every 10-K, 10-Q, 8-K, and proxy statement into clear takeaways, flags accounting changes, and links figures back to semiconductor capacity cycles. You receive real-time alerts the moment a filing hits EDGAR, so there’s no waiting to see if a new Asian lab expansion appears in an 8-K or if rising depreciation squeezes margins in the next 10-Q.
- See Trio Tech International insider trading Form 4 transactions within seconds of submission.
- Dive into each Trio Tech International quarterly earnings report 10-Q filing with instant margin trend charts.
- Monitor Trio Tech International Form 4 insider transactions real-time alongside price moves.
- Get concise Trio Tech International earnings report filing analysis without scrolling hundreds of pages.
- Use our dashboards for understanding Trio Tech International SEC documents with AI—from revenue by segment to backlog shifts.
- Follow Trio Tech International executive stock transactions Form 4 before major equipment orders are announced.
- Read the Trio Tech International annual report 10-K simplified for cap-ex plans and real-estate valuations.
- Compare pay packages with the Trio Tech International proxy statement executive compensation summary.
- Catch breaking news through Trio Tech International 8-K material events explained—from lab openings to supply-chain disruptions.
Whether you’re gauging utilisation rates, segment profitability, or management’s trading patterns, our AI-powered summaries, real-time updates, and expert context turn Trio Tech’s intricate disclosures into actionable insights in minutes, not hours.
Trio-Tech International (TRT) – Form 4 filing dated 07/08/2025 discloses that Chief Financial Officer Anitha Srinivasan was granted 10,000 non-qualified stock options on 07/07/2025. The options carry an exercise price of $5.24 per share and expire on 07/06/2030. Vesting schedule: 2,500 options vest immediately; the remaining 7,500 vest in three equal annual installments thereafter. After the grant, the executive beneficially owns 10,000 derivative securities, all held directly. No shares were bought or sold, and no cash changed hands at the time of grant (price reported as $0).
The filing represents a routine equity-based compensation award designed to align the CFO’s incentives with shareholder value and support retention. The 10,000-share option grant could introduce modest future dilution, but the impact appears limited given the small size relative to typical public-company share counts. No other insider transactions or financial data are included in the document.
Trio-Tech International (TRT) filed a Form 4 indicating that Senior Corporate Vice President & COO (Testing) Lim Hwee Poh received a grant of 10,000 stock options on 07/07/2025 at an exercise price of $5.24 per share, expiring on 07/06/2030. The filing was submitted on 07/08/2025.
Of the total award, 2,500 options vested immediately, while the remaining 7,500 options will vest in three equal annual installments. After the transaction, the executive’s beneficial ownership stands at 10,000 derivative securities, held directly. No common shares were bought or sold and there were no dispositions of existing equity.
This is a routine equity-based compensation grant intended to align the executive’s interests with shareholders. The award is modest relative to the company’s total shares outstanding and has minimal immediate dilution or cash-flow impact. Investors may view the filing as neutral, providing limited insight into near-term sentiment or operational performance.
Trio-Tech International (NYSE American: TRT) has converted its Chinese testing subsidiary Trio-Tech (Jiangsu) Co. Ltd. into a wholly-owned entity. On 30 June 2025, the company’s intermediate subsidiary, Trio-Tech (SIP) Co., Ltd., purchased the remaining 49% equity interest in Trio-Tech Jiangsu from Suzhou Anchuang Technology Management LLP. Prior to the transaction, Trio-Tech SIP already held 51% of the shares; closing the deal gives Trio-Tech International 100% indirect ownership of the Jiangsu operation. The filing, disclosed under Item 8.01 of an 8-K dated 7 July 2025, contains no purchase price or financial metrics but signals a strategic move to simplify the group structure, gain full operational control, and consolidate all future revenues and earnings from the Jiangsu unit.